top of page
Profile
Join date: Dec 18, 2019
Posts (274)
May 30, 2025 ∙ 4 min
New potential treatment strategy for brain metastases and leptomeningeal disease: HER3-DXd shows promising results in the phase II TUXEDO-3 study for patients with limited therapeutic options
The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel anti-cancer drug in...
451
0
Apr 22, 2025 ∙ 2 min
From Barcelona to Boston: MEDSIR Celebrates 13 Years Advancing Global Cancer Research Through Innovation and international Collaboration
Over 2,600 patients, 600 researchers and more than 60 clinical trials: Born in Barcelona 13 years ago, MEDSIR’s model proves that...
68
0
Feb 26, 2025 ∙ 4 min
MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gileads Trodelvy® in Advanced Breast Cancer
WIN-B ( NCT06612203 ) is a Phase Ib/II, multi-center investigator-initiated trial, evaluating the safety and preliminary efficacy of...
180
0
MedSIR
Admin
More actions
bottom of page